Veterinary Medicine Information website

Porcilis APP Vet. injektionsvæske, suspension

Authorised
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, outer membrane protein
  • Actinobacillus pleuropneumoniae, APX III toxoid
Download as PDF

Product identification

Medicine name:
Porcilis APP Vet. injektionsvæske, suspension
Active substance:
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, outer membrane protein
  • Actinobacillus pleuropneumoniae, APX III toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, APX I toxoid
    500.00
    unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX II toxoid
    500.00
    unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, outer membrane protein
    10000.00
    unit(s)
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX III toxoid
    100000.00
    unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 16742
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 10/12/2025
Download